ConsumerLab.com uses JavaScript to provide the best possible experience for our content, but your browser has it disabled. Learn how to enable it here.

About ConsumerLab.com

Latest Posted May 30, 2024

Young Living Essential Oils Agrees to Pay $5 Million to Settle Lawsuit

Young Living Essential Oils has agreed to pay up to $5 million to settle a class action lawsuit that charged the company with promoting its essential oils to reduce stress and anxiety, improve sleep, and other health-related claims without reliable scientific evidence.

The lawsuit also alleged that Young Living marketed its lavender, peppermint, and other essential oils as “therapeutic grade,” without providing evidence to support this claim, citing a ruling by the National Advertising Review Board in November 2020 that Young Living should discontinue use of this term because it was “unsupported.” At that time, Young Living agreed to comply and permanently discontinue the claim that its products are therapeutic. The company was warned by the FDA in 2022 for making claims its products could treat seasonal allergies, kidney stones, and other health conditions.

[See ConsumerLab’s Lavender and Tea Tree Essential Oils Review for tests of products and our Top Picks among essential oils. The Review also discusses the clinical evidence for essential oils for anxiety, sleep, pain, and other conditions.]

As part of the settlement agreement, consumers who purchased Young Living essential oils for personal use between January 1, 2017, through April 25, 2024 are eligible to receive a refund of up to $2 per product up to a maximum of $20. Consumers who wish to submit a claim must do so by June 24, 2024.

For more information, use the link below.

Class Action Settlement: MacNaughton, et al. v. Young Living Essential Oils, LC

See related recalls and warnings:

Young Living Warned for Promoting Essential Oils to Treat Seasonal Allergies, Kidney Stones & More

Sellers of Essential Oils Warned for Claiming to Treat Ebola, Other Diseases

Complaint Submitted to FTC for doTerra Essential Oil COVID Claims